A Promising Heart Drug Failed. What Went So Wrong?
Cardiologists are struggling to figure out why a drug that should have prevented heart attacks didn’t work at all.
Link that bypasses the paywall:
archive.isArchived web pagearchive.isQuoted:
But the failure of the Novartis study raised an uncomfortable possibility: Maybe Lp(a) is not a cause of heart disease, but instead is a marker of heart disease risk, like white hair is a mark of aging.
If Lp(a) is a marker, though, what is it marking? Is there another cause of heart disease that no one has thought of?
That is “the nagging question we are all pondering,” said Dr. David Maron, president of the American Society for Preventive Cardiology.
There may not be an easy answer, either. “Maybe we were fooled into thinking this would be simple,” Dr. Alexander said.
Still, many researchers are not ready to throw out the Lp(a) hypothesis, saying that there might be other explanations for the failure and that they need to take a close look at the study data. The company will not provide the full data set until it is presented at the American Heart Association meeting in December.



